BIO-key International, Inc.
BKYI
$0.8548
$0.03484.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 9.91% | -31.82% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.91% | -31.82% | |||
| Cost of Revenue | 6.52% | -43.58% | |||
| Gross Profit | 10.65% | -28.56% | |||
| SG&A Expenses | -25.94% | 15.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.66% | 0.17% | |||
| Operating Income | 49.46% | -118.40% | |||
| Income Before Tax | 47.67% | -90.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 46.80% | -87.35% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 46.80% | -87.35% | |||
| EBIT | 49.46% | -118.40% | |||
| EBITDA | 53.70% | -144.17% | |||
| EPS Basic | 65.70% | -16.78% | |||
| Normalized Basic EPS | 66.25% | -18.70% | |||
| EPS Diluted | 65.70% | -16.78% | |||
| Normalized Diluted EPS | 66.25% | -18.70% | |||
| Average Basic Shares Outstanding | 55.08% | 60.46% | |||
| Average Diluted Shares Outstanding | 55.08% | 60.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||